文章基本信息

标题：Australian Gonococcal Surveillance Programme, 1 July to 30 September 2013
本地全文：下载
作者：Monica M Lahra
期刊名称：Communicable Diseases Intelligence
印刷版ISSN：1447-4514
电子版ISSN：1445-4866
出版年度：2013
卷号：37
期号：4
出版社：Government Department of Health and Ageing
摘要：The Australian National Neisseria Network reference laboratories in each State and Territory report data quarterly on sensitivity to an agreed group of antimicrobial agents, for the Australian Gonococcal Surveillance Programme (AGSP). The antibiotics routinely tested and reported are penicillin, ceftriaxone, ciprofloxacin and spectinomycin which are current or potential agents used for the treatment of gonorrhoea. Azithromycin testing is now performed by all states and territories as it has a role as part of a dual therapy regimen in the treatment of gonorrhoea. When in vitro resistance to a recommended agent is demonstrated in 5% or more of isolates from a general population, it is usual to remove that agent from the list of recommended treatments.1 Additional data are also provided on other antibiotics from time to time. These data are reported in the AGSP annual report. The AGSP has a program-specific quality assurance process. Because of the substantial geographic differences in susceptibility patterns in Australia, regional as well as aggregated data are presented. The AGSP data are presented quarterly in tabulated form, as well as in the AGSP annual report.